Strategy filed an 8-K on November 4, 2025, disclosing the execution of an Omnibus Sales Agreement that collapses five separate at-the-market offering programs into a single coordinated facility. The combined remaining capacity across all five share classes totals approximately $46.2 billion. No new authorization was created. Every dollar in the new agreement equals what was left unsold under the prior programs at the moment they were terminated.

One Agreement, Five Share Classes

The Omnibus Sales Agreement covers five distinct securities. Common stock carries a remaining capacity of approximately $15.85 billion. STRK preferred stock accounts for the largest single tranche at approximately $20.34 billion. STRC preferred stock adds $4.2 billion, STRD preferred stock adds approximately $4.13 billion, and STRF preferred stock rounds out the facility at approximately $1.66 billion. The filing explicitly states that these amounts equal the unsold balances from the terminated prior programs, making this a structural consolidation rather than a capital raise.

The agent roster spans TD Securities, Barclays Capital, Canaccord Genuity, Cantor Fitzgerald, BTIG, The Benchmark Company, Clear Street, and Compass Point Research and Trading, among others. Commissions are capped at 2.0% of gross proceeds per sale. The company retains full discretion over timing, amount, and which share class to offer on any given day. The agents carry no obligation to sell, and Strategy carries no obligation to issue.

Why the Consolidation Matters for Capital Markets Execution

Running five separate ATM programs creates administrative friction. Each program has its own prospectus supplement, its own agent coordination, and its own tracking obligations. Consolidating into a single omnibus structure with annex-based prospectus supplements for each share class simplifies the mechanics of issuing across the capital stack. When Strategy decides to draw on preferred capacity one week and common stock the next, a single agreement reduces the operational overhead of switching between programs.

The practical consequence for observers is that future ATM activity will flow through one filing reference rather than five. Tracking issuance across the capital stack becomes cleaner. The filing also preserves the ability to launch additional at-the-market offerings under the same umbrella structure, which the 8-K cites as one of the consolidation's stated purposes.

The Filing Fits a Ceiling-Level Disclosure Pattern

$MSTR's Filing Risk Score sits at 100, and Event Momentum matches it. Both reflect the density and severity of capital markets filings Strategy generates, not financial distress. This 8-K is a procedural event inside that pattern. The elevated disclosure cadence is the context, and this filing is one more data point in it.

Strategy disclosed aggregate fair market value of approximately $64.04 billion as of April 26, 2026, per the May 6, 2026 10-Q. That position scale is what makes the capital markets infrastructure matter. A company holding Bitcoin at that scale needs a capital stack that can be managed efficiently, and the Omnibus Sales Agreement is part of that infrastructure.

$MSTR's 90-day price performance through May 20, 2026 shows a gain of approximately 26.5%, though the stock remains well below its 52-week high set in July 2025. The short-term trend is up while the longer-term trend remains down, a split that reflects how much ground was lost from the 2025 peak. The BTC Exposure Score of 85 anchors the equity's research case directly to Bitcoin price and capital structure mechanics, not software operations.

What the Next Filing Would Change

The Omnibus Sales Agreement sets the capacity ceiling. What matters next is the pace of drawdown. Watch for 424B filings and prospectus supplement updates that show actual sales activity under the new agreement. A cluster of common stock issuances would signal that Strategy is leaning on equity to fund Bitcoin accumulation. Preferred stock issuances would indicate a different cost-of-capital calculation. The agreement itself is neutral on that question. The drawdown pattern will answer it.

Research only. Not investment advice.